Press Release Author = Luke Scicluna / Novexin Ltd
Industry = Biotech
Press Release Summary = Novexin reports rapidly increasing sales of its novel InstantBlue single step protein gel stain.
Press Release Body = Cambridge, UK: Novexin Ltd (www.novexin.com) the innovative company specialising in improved technologies and products for protein science reports rapidly increasing sales of their novel InstantBlue product.
InstantBlue, based on the Coomassie blue stain, provides two key advantages over other available products for straining protein bands in SDS-PAGE gels:
.It provides a result in 15 minutes compared with 1 hour typical for competing products .It requires a one step procedure and eliminates the multi-step requirements of other products.
Since its launch in July 2006 sales of InstantBlue have grown rapidly bringing in new customers worldwide. Novexin is already selling to over 200 different companies, including major biotech and pharmaceutical companies with the product showing its popularity though reorders and recommendations.
Dr Dan Jones Director of Novexin states "Through InstantBlue we have applied our technology to a procedure used routinely in most labs concerned with proteins to give our customers more rapid results and increased productivity. Our rapidly expanding sales of this product reflect the positive impact this has had in industry and academia. In both areas we have had an excellent uptake rate both in the UK and abroad"
Clare Stevenson from the John Innes Centre commented "Does exactly what it says on the container - A small quantity is added directly to the gel and the protein bands are visible in minutes; no need to wash or destain the gel; quicker and easier than other stains on the market and just as sensitive"
While Dr Mark Abbot from, AstraZeneca commented "Instant Blue means I can plan my next experiment within 5 minutes rather than having to wait for 2-3 hours to stain and destain a gel."
With this product Novexin has continued with their aim to provide effective solutions to common problems in protein science, concentrating on simplicity in design and effectiveness in applicability.
2022
